UNSPSC 51434936: Hydralazine/isosorbide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434936 Hydralazine/isosorbide, a Commodity code, covers prescription and advanced life support medications procured by state and local health agencies, fire rescue services, and pharmacy benefit programs. State and local buyers under this code are acquiring specific pharmaceutical products — including advanced life support injectable medications, generic multi-source pharmaceuticals, and over-the-counter products — for use in emergency medical services, institutional healthcare facilities, and state employee and Medicaid pharmacy benefit programs. Issuing bodies span city fire departments, state health and human services agencies, and cooperative purchasing alliances that aggregate demand across multiple states and local jurisdictions. The work involves vendor selection based on product availability, pricing competitiveness, regulatory compliance (cGMP, DSCSA, FDA standards), and supply chain logistics including expiration-date management and delivery timelines.

Recent activity shows geographic spread across Florida, Texas, and Minnesota, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) serving as a multi-state aggregator. Representative opportunities include the City of Tampa's sealed-bid procurement (IFB No. 26P00188, due April 8, 2026, estimated value $40,000) for advanced life support medications including Labetalol, Epinephrine, Adenosine, and Diltiazem to supply Tampa Fire Rescue; the Texas Health and Human Services Commission's Request for Information (RFI HHS0017013, posted April 3, 2026) exploring direct-to-manufacturer prescription fulfillment strategies; and MMCAP's RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson), with contract effectiveness July 1, 2026 and two-year initial terms. Tampa's solicitation includes a 5 percent bid discount for Small Local Business Enterprise participation. Vendors must maintain comprehensive insurance, demonstrate pricing flexibility across multiple formats, certify regulatory compliance, and manage logistics including pickup and replacement of expired inventory before nine-month expiration thresholds.